Ability Biotherapeutics
Ability Biotherapeutics is a biotherapeutic targeting company focused on developing innovative, targeted, immune-modulating biotherapeutics for unmet medical needs in cancer and autoimmune diseases. Their proprietary AbiLeap™ discovery engine leverages generative AI and a vast database of antigen-antibody interactions to create fully human, highly specific, and selective multispecific antibodies. These antibodies are designed to be conditionally activated by environmental signals within the cellular microenvironment, enabling logic-gated therapeutics with reduced toxicity and a broadened therapeutic window. The company aims to revolutionize targeted therapeutics to improve patient outcomes and set new industry standards.
Ability Biotherapeutics
Ability Biotherapeutics is a biotherapeutic targeting company focused on developing innovative, targeted, immune-modulating biotherapeutics for unmet medical needs in cancer and autoimmune diseases. Their proprietary AbiLeap™ discovery engine leverages generative AI and a vast database of antigen-antibody interactions to create fully human, highly specific, and selective multispecific antibodies. These antibodies are designed to be conditionally activated by environmental signals within the cellular microenvironment, enabling logic-gated therapeutics with reduced toxicity and a broadened therapeutic window. The company aims to revolutionize targeted therapeutics to improve patient outcomes and set new industry standards.